Elan makes new board appointment

ELAN has announced the appointment of William Rohn to the company’s board of directors.

Mr Rohn has extensive experience in the biotech and pharmaceutical industry. He is currently vice-chairman of Raven Biotechnologies and a director of Metabasis Therapeutics, Cerus and Pharmacyclics.

He was formerly chief operating officer of Biogen Idec.